Pharmacological Biomarkers

Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).

Also Known As:

Biomarkers, Pharmacological; Drug Dosing Biomarkers; Drug Response Biomarkers; Drug Safety Biomarkers; Biomarker, Drug Dosing; Biomarkers, Drug Dosing; Biomarkers, Drug Response; Biomarkers, Drug Safety; Dosing Biomarker, Drug; Dosing Biomarkers, Drug; Markers, Pharmacological Biological; Pharmacological Biological Markers; Response Biomarkers, Drug; Safety Biomarkers, Drug; Biological Markers, Pharmacological; Drug Dosing Biomarker

Networked: 14 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Biological Factors: 2472
- Biomarkers: 240291
  - Pharmacological Biomarkers: 14

Experts

1.	Gnudi, Luigi: 2 articles (11/2020 - 12/2019)
2.	Ricciardi, Carlo Alberto: 2 articles (11/2020 - 12/2019)
3.	Correia, Inês: 1 article (01/2021)
4.	De Carvalho, Sara: 1 article (01/2021)
5.	Faustino, Ricardo: 1 article (01/2021)
6.	Palavra, Filipe: 1 article (01/2021)
7.	Pinto, Joana: 1 article (01/2021)
8.	Sousa, Lívia: 1 article (01/2021)
9.	Vasconcelos, Mónica: 1 article (01/2021)
10.	Bild, Andrea H: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2016 - "We expect GR metrics to improve the study of cell signaling and growth using small molecules and biologics and to facilitate the discovery of drug-response biomarkers and the identification of drugs effective against specific patient-derived tumor cells." 01/01/2017 - "Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies." 01/01/2021 - "However, efforts to develop prognostic and drug response biomarkers largely rely on bulk 'omic' data, which fails to capture intratumor heterogeneity (ITH) and deconvolve signals from normal versus tumor cells. " 03/28/2018 - "Identifying reliable drug response biomarkers is a significant challenge in cancer research. " 12/17/2009 - "Such drug response biomarkers will be instrumental to individualize the therapy of patients having seemingly similar cancers. "
2.	Multiple Sclerosis 01/04/2021 - "Extensive studies of children, adolescents and adults with multiple sclerosis will be needed to categorize the clinical and radiological differences that allow the identification of drug response biomarkers in the early stages of the disease. "
3.	Chronic Renal Insufficiency 12/09/2019 - "The identification of new biomarkers/pharmacological targets for chronic kidney disease (CKD) is required for the development of more effective therapies. "
4.	Psoriatic Arthritis 01/01/2020 - "Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS."
5.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/01/2019 - "In this review, we discuss the role of cytokines involved in the pathogenesis and in the therapy of inflammatory bowel diseases, and their putative use as pharmacological biomarkers of therapy responsiveness."

Related Drugs and Biologics

1.	Cytokines
2.	Biomarkers (Surrogate Marker)
3.	Peptides (Polypeptides)
4.	Carbon Tetrachloride (Tetrachloromethane)
5.	pien tze huang

Related Therapies and Procedures

1.	Therapeutics